Jim Cramer Says 'There's Too Much Political Risk' For This Stock Is Up 106% In 2022

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Rocket Pharmaceuticals Inc RCKT is a "very early stage company that has a lot in the pipe. I tend to like these companies."

Analysts agree, Bezinga's Analyst Ratings data shows a consensus Buy rating, with all 10 analysts bullish on RCKT.

When asked about Sociedad Quimica y Minera de Chile SA SQM, he said, "I think there’s too much political risk." Analysts, however, have a consensus Buy rating on SQM.

Plug Power Inc PLUG is "losing a fortune," he said. "They must get expenses under control."

Cramer said Anavex Life Sciences Corp AVXL is "another one that I kind of like, I’ve got to tell you." However, he added, "I do not like losses in tech, but in biotech I can accept the fact that they have a good pipeline."

Also Read: Tesla Could Drop To $150 Before Year-End — Analyst Smells 'Window Of Opportunity' For Investors

When asked about GoPro Inc GPRO, Cramer said, "I just don’t think that they’re doing well enough to recommend."

Cramer said Illinois Tool Works Inc ITW is the "kind of stock that is doing incredibly well."

When asked about Ryan Specialty Holdings Inc RYAN, he said, "I’ve got to find out what the hell went wrong with that one last week. " He added, "It’s usually a very normal, kind of regular company, and it got slammed."

Cramer said Shockwave Medical Inc SWAV is a "good company, very expensive stock, though."

Photo: Courtesy of Owen Byrne on flickr